Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer

Robert Słotwiński; Sylwia Małgorzata Słotwińska

doi:10.5114/ceji.2016.65140

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

4/2016
vol. 41

Send email

Copy url:

abstract:

Review paper

Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer

Robert Słotwiński

,

Sylwia Małgorzata Słotwińska

(Cent Eur J Immunol 2016; 41 (4): 404-418)

DOI: https://doi.org/10.5114/ceji.2016.65140

Online publish date: 2017/01/24

View full text Get citation

PlumX metrics:

Disorders of innate antibacterial response are of fundamental importance in the development of gastrointestinal cancers, including pancreatic cancer. Multi-regulatory properties of the Toll-like receptors (TLRs) (e.g., regulation of proliferation, the activity of NF-κB, gene transcription of apoptosis proteins, regulation of angiogenesis, HIF-1α protein expression) are used in experimental studies to better understand the pathogenesis of pancreatic cancer, for early diagnosis, and for more effective therapeutic intervention. There are known numerous examples of TLR agonists (e.g., TLR2/5 ligands, TLR6, TLR9) of antitumor effect. The direction of these studies is promising, but a small number of them does not allow for an accurate assessment of the impact of TLR expression disorders, proteins of these signaling pathways, or attempts to block or stimulate them, on the results of treatment of pancreatic cancer patients. It is known, however, that the expression disorders of proteins of innate antibacterial response signaling pathways occur not only in tumor tissue but also in peripheral blood leukocytes of pancreatic cancer patients (e.g., increased expression of TLR4, NOD1, TRAF6), which is one of the most important factors facilitating further tumor development. This review mainly focuses on the genetic aspects of signaling pathway disorders associated with innate antibacterial response in the pathogenesis and diagnosis of pancreatic cancer.

keywords:

Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer

Robert Słotwiński , Sylwia Małgorzata Słotwińska

pancreatic cancer, Toll-like receptors, signaling pathways

Robert Słotwiński

,

Sylwia Małgorzata Słotwińska